TARSUS PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 5362000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-09-30) |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dbb3a27e-383a-4112-a87c-2f67e1a251f1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-23-000080Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/accounts-receivable/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dbb3a27e-383a-4112-a87c-2f67e1a251f1
History
- no predecessors — first report